Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study. - Bae JH; Lee YJ; Park JB; Baek JE; Hong SW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim KO; et al. (Therapeutic advances in gastroenterology, 2025)